GGrantIndex
← Leaderboards

Ming Zhao

Northwestern University

$8,073,538
Attributed
$12,567,443
Total exposure
10
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.5M · FY200825
$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$12,567,443 · 10

By mechanism

R01$10,041,924 · 5
R21$1,425,519 · 3
S10$1,100,000 · 2

Top collaborators

Most similar at Northwestern University

Same institution · by research overlap

Others in their field

Top investigators on “Image

Research focus

ImageMolecularSpecificityTissuesImpairmentPhosphatidylethanolaminePathway InteractionsSignal TransductionCellsLeadResponseFunctional DisorderMeasurementImaging TechniquesAffinityPublic Health RelevanceIn VivoChronicInjuryNecrosisAcuteCell DeathMediatingBase

Grant awards (29)

Rationally Designed, Target-specific Imaging Probes for Nephro-urology Diagnoses$579,236
R01 · FY2025 · EB
The identification and pathophysiology of non-infarcted but injured myocardium in the post-ischemic heart$729,842
R01 · FY2024 · HL · contact PI
Rationally Designed, Target-specific Imaging Probes for Nephro-urology Diagnoses$565,566
R01 · FY2024 · EB
The identification and pathophysiology of non-infarcted but injured myocardium in the post-ischemic heart$755,936
R01 · FY2023 · HL · contact PI
Rationally Designed, Target-specific Imaging Probes for Nephro-urology Diagnoses$577,163
R01 · FY2023 · EB
Differentiating clinical characteristics between two subtypes of antiphosphatidylethanolamine$200,000
R21 · FY2023 · AI · contact PI
The identification and pathophysiology of non-infarcted but injured myocardium in the post-ischemic heart$763,064
R01 · FY2022 · HL · contact PI
Differentiating clinical characteristics between two subtypes of antiphosphatidylethanolamine$240,000
R21 · FY2022 · AI · contact PI
The identification and pathophysiology of non-infarcted but injured myocardium in the post-ischemic heart$766,173
R01 · FY2021 · HL · contact PI
E2F1 in BM progenitor cell differentiation and cardiovascular repair$350,992
R01 · FY2019 · HL
The pathogenic mechanism of anti-phosphatidylethanolamine antibodies$208,560
R21 · FY2019 · AR · contact PI
E2F1 in BM progenitor cell differentiation and cardiovascular repair$351,661
R01 · FY2018 · HL
The pathogenic mechanism of anti-phosphatidylethanolamine antibodies$173,800
R21 · FY2018 · AR · contact PI
(PQD5) imaging systemic tissue injuries induced by anticancer drugs$496,930
R01 · FY2017 · CA · contact PI
E2F1 in BM progenitor cell differentiation and cardiovascular repair$358,746
R01 · FY2017 · HL
(PQD5) imaging systemic tissue injuries induced by anticancer drugs$495,263
R01 · FY2016 · CA · contact PI
E2F1 in BM progenitor cell differentiation and cardiovascular repair$395,894
R01 · FY2016 · HL
(PQD5) imaging systemic tissue injuries induced by anticancer drugs$490,647
R01 · FY2015 · CA · contact PI
A SPECT_CT Scanner for Preclinical Imaging Studies$600,000
S10 · FY2014 · OD · contact PI
(PQD5) imaging systemic tissue injuries induced by anticancer drugs$488,338
R01 · FY2014 · CA · contact PI
Imaging Vascular Phosphatidylethanolamine$363,300
R01 · FY2014 · HL · contact PI
Imaging Vascular Phosphatidylethanolamine$356,964
R01 · FY2013 · HL · contact PI
Imaging Vascular Phosphatidylethanolamine$382,590
R01 · FY2012 · HL · contact PI
Imaging Vascular Phosphatidylethanolamine$379,195
R01 · FY2011 · HL · contact PI
Microspect Scanner for Small Animal Radionuclide Imaging$500,000
S10 · FY2010 · RR · contact PI
Imaging Vascular Phosphatidylethanolamine$394,424
R01 · FY2010 · HL · contact PI
Making Embryonic Stem Cells Infarct Avid$227,250
R21 · FY2009 · HL · contact PI
Making Embryonic Stem Cells Infarct Avid$186,534
R21 · FY2009 · HL · contact PI
Making Embryonic Stem Cells Infarct Avid$189,375
R21 · FY2008 · HL · contact PI